DPH2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.283600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.891000E-01
Normal-vs-Stage2
9.810000E-01
Normal-vs-Stage3
3.299600E-01
Normal-vs-Stage4
7.060000E-01
Stage1-vs-Stage2
8.185600E-01
Stage1-vs-Stage3
1.315780E-01
Stage1-vs-Stage4
3.524200E-01
Stage2-vs-Stage3
2.294000E-01
Stage2-vs-Stage4
7.023000E-01
Stage3-vs-Stage4
9.714200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.258200E-01
Normal-vs-AfricanAmerican
7.496400E-01
Normal-vs-Asian
6.958400E-01
Caucasian-vs-AfricanAmerican
4.434000E-01
Caucasian-vs-Asian
5.819000E-01
AfricanAmerican-vs-Asian
4.557400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.964000E-01
Normal-vs-Female
9.778400E-01
Male-vs-Female
6.525600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.320000E-01
Normal-vs-Age(41-60Yrs)
9.495000E-01
Normal-vs-Age(61-80Yrs)
8.542000E-01
Normal-vs-Age(81-100Yrs)
8.932000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.543200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.930800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.326400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.083000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.255800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.806800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.089200E-01
Normal-vs-Daily Drinker
9.535600E-01
Normal-vs-Weekly Drinker
7.848800E-01
Normal-vs-Occasional Drinker
9.228400E-01
Normal-vs-Social Drinker
7.299800E-01
Non Drinker-vs-Daily Drinker
6.618400E-01
Non Drinker-vs-Weekly Drinker
9.872600E-01
Non Drinker-vs-Occasional Drinker
4.210200E-01
Non Drinker-vs-Social Drinker
2.516000E-01
Daily Drinker-vs-Weekly Drinker
6.953800E-01
Daily Drinker-vs-Occasional Drinker
7.741600E-01
Daily Drinker-vs-Social Drinker
5.441800E-01
Weekly Drinker-vs-Occasional Drinker
4.898200E-01
Weekly Drinker-vs-Social Drinker
3.066800E-01
Occasional Drinker-vs-Social Drinker
6.157400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.962800E-01
Normal-vs-Grade 2
8.894600E-01
Normal-vs-Grade 3
9.043600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.091000E-01
Grade 1-vs-Grade 3
6.140000E-01
Grade 1-vs-Grade 4
6.962800E-01
Grade 2-vs-Grade 3
7.394400E-01
Grade 2-vs-Grade 4
8.894600E-01
Grade 3-vs-Grade 4
9.043600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.338600E-01
Normal-vs-NonDiabetic
7.922600E-01
Diabetic-vs-NonDiabetic
8.800600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.389800E-01
Normal-vs-NoPancreatitis
8.069600E-01
Pancreatitis-vs-NoPancreatitis
3.262800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.474000E-01
Normal-vs-N1
9.762200E-01
N0-vs-N1
6.625000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.772600E-01
Normal-vs-TP53-NonMutant
9.413200E-01
TP53-Mutant-vs-TP53-NonMutant
3.275600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
